We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Valeo Pharma Inc | TSX:VPH | Toronto | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.005 | -4.35% | 0.11 | 0.105 | 0.12 | 0.11 | 0.11 | 0.11 | 2,065 | 14:30:00 |
From May 2022 to May 2024
TORONTO, May 9, 2022 /CNW/ - Steve Saviuk, Chief Executive Officer, Frederic Fasano, President and Chief Operating Officer, Luc Mainville, Senior Vice-President and Chief Financial Officer, Valeo Pharma Inc. ("Valeo" or the "Company") (TSX: VPH) and their team joined Daniel Lubienietzky, Manager, Life Sciences, Toronto Stock Exchange, to celebrate the Company's new listing on Toronto Stock Exchange and open the market.
Headquartered in Kirkland, Quebec, Valeo Pharma is a Canadian specialty pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada, with a focus on respirology, neurodegenerative diseases, oncology and other specialty products.
Date: Monday, May 9, 2022
Time: 9:00am - 9:30am
Place: 120 Adelaide St W.
SOURCE Toronto Stock Exchange
Copyright 2022 Canada NewsWire
1 Year Valeo Pharma Chart |
1 Month Valeo Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
